Description
Elidel (Pimecrolimus) Cream 1% 15 g
Ingredients
Active ingredient: Pimecrolimus 1%
Other ingredients: Stearyl alcohol, white soft paraffin, propylene glycol, mono- and di-glycerides of caprylic/capric acid, and benzyl alcohol.
Mechanism of Action
Pimecrolimus exerts its anti-inflammatory effects by inhibiting the activation of T-lymphocytes and mast cells, thereby reducing the inflammatory response in atopic dermatitis.
Pharmacological Properties
Elidel cream contains pimecrolimus, which acts as a calcineurin inhibitor, modulating the immune response in the skin.
Indications for Use
Elidel cream is indicated for the short-term and intermittent long-term treatment of mild to moderate atopic dermatitis in non-immunocompromised patients.
Contraindications
Do not use Elidel cream in patients with a history of hypersensitivity to pimecrolimus or any of the ingredients in the formulation.
Side Effects
Common side effects of Elidel cream may include burning sensation, itching, or redness at the application site. Consult a healthcare provider for a complete list of possible side effects.
Usage Instructions
Apply a thin layer of Elidel cream to the affected skin twice daily. Rub in gently and completely. Wash hands after application.
Benefits Compared to Analogues
Elidel cream offers a targeted approach to managing atopic dermatitis with reduced risk of systemic side effects compared to traditional corticosteroids.
Suitable Patient Groups
Elidel cream is suitable for use in both pediatric and adult populations for the treatment of atopic dermatitis.
Storage Conditions and Shelf Life
Store Elidel cream at room temperature away from moisture and heat. Check the expiration date on the packaging and do not use the product if expired.
Packaging Description
Elidel cream is available in a tube containing 15 g of 1% pimecrolimus cream.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the efficacy of Elidel cream in improving symptoms and reducing flare-ups in patients with atopic dermatitis. Clinical trials have shown comparable effectiveness to traditional corticosteroids with a lower risk of side effects.
